ArticleTranslational vision science & technology2025
Ocular Characteristics and Genotype-Oriented Disease Spectrum of Alström Syndrome in Taiwan.
Article in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Endocrine metabolism characteristics of Alström syndrome in 25 Chinese patients and identification of a new splice site in the ALMS1 gene.Diabetology & metabolic syndrome · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to describe the ophthalmological features of Alström syndrome, a rare syndromic ciliopathy, and to delineate the genotype-associated disease spectrum. Methods: Eight Taiwanese patients were recruited for this study. Pathogenic variants were identified using next-generation sequencing, and medical records were reviewed for systemic involvement. Best-corrected visual acuity, cycloplegic refraction, blue light fundus autofluorescence imaging, International Society for Clinical Electrophysiology of Vision-standard full-field flash electroretinography, optical coherence tomography, and visual field testing were obtained and studied retrospectively. Results: Common ocular manifestations included hyperopia, nystagmus, photophobia, and visual impairment. Most patients also exhibited obesity, sensorineural hearing loss, and developmental delays. Phenotype variability was observed in age of onset (0-8 years), severity of visual impairment, and extent of extraocular involvement. Electroretinography results reflected varying degrees of retinal degeneration. We identified c.11110_11128del as a genotype frequently occurring in Asian populations that demonstrated a more severe phenotype within our cohort. In addition, we discovered three novel variants, including a LINE-1 insertion in exon 8 (c.3565insL1), c.6166_6167insAT, and 8077del. Conclusions: Alström syndrome may manifest with early-onset ocular and syndromic features, or demonstrate a later onset with limited extraocular involvement. This is the first report of a LINE-1 insertion in ALMS1, with affected patients exhibiting comparatively mild phenotypes. Translational Relevance: Combined ophthalmological and extraocular phenotypes combined may aid in diagnosing this rare disease and differentiating it from other possible causes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.